Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Erika Langsfeld

TitleAffiliate
InstitutionUniversity of Colorado Boulder
DepartmentBiofrontiers Institute

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Chaudhary N, Coleman HJ, Paolone EV, Yu J, Ledbetter AW, Lemnios AA, Walsh AA, Suh H, Wang A, Mansoor MM, Giancola JB, Melo MB, Rauch AM, Langsfeld ES, Parlikar UR, Pacheco MO, Williams CA, Funke HH, Garcea RL, Randolph TW, Irvine DJ. Atomic layer deposition for core-shell microparticle vaccines enabling programmable antigen delivery to lymph nodes enhance humoral immune responses. bioRxiv. 2026 Jun 02. PMID: 42282721.
      View in: PubMed
    2. Coleman HJ, Rauch A, Langsfeld E, Anderson K, Parlikar U, Funke HH, Garcea RL, Randolph TW. Lipid-free, thermostable mRNA vaccines prepared using atomic layer deposition. J Pharm Sci. 2026 Feb; 115(2):104066. PMID: 41241219.
      View in: PubMed
    3. Erickson KD, Langsfeld ES, Holland A, Ebmeier CC, Garcea RL. Proteome profiling of polyomavirus nuclear replication centers using iPOND. J Virol. 2024 11 19; 98(11):e0079024. PMID: 39480110.
      View in: PubMed
    4. Langsfeld E, Laimins LA. Human papillomaviruses: research priorities for the next decade. Trends Cancer. 2016 May; 2(5):234-240. PMID: 27617309.
      View in: PubMed
    5. Langsfeld ES, Bodily JM, Laimins LA. The Deacetylase Sirtuin 1 Regulates Human Papillomavirus Replication by Modulating Histone Acetylation and Recruitment of DNA Damage Factors NBS1 and Rad51 to Viral Genomes. PLoS Pathog. 2015 Sep; 11(9):e1005181. PMID: 26405826.
      View in: PubMed
    6. Joste NE, Ronnett BM, Hunt WC, Pearse A, Langsfeld E, Leete T, Jaramillo M, Stoler MH, Castle PE, Wheeler CM. Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer. Cancer Epidemiol Biomarkers Prev. 2015 Jan; 24(1):230-40. PMID: 25363635.
      View in: PubMed
    7. Wheeler CM, Hunt WC, Cuzick J, Langsfeld E, Robertson M, Castle PE. The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States. Int J Cancer. 2014 Aug 01; 135(3):624-34. PMID: 24226935.
      View in: PubMed
    8. Castle PE, Hunt WC, Langsfeld E, Wheeler CM. Three-year risk of cervical precancer and cancer after the detection of low-risk human papillomavirus genotypes targeted by a commercial test. Obstet Gynecol. 2014 Jan; 123(1):49-56. PMID: 24463663.
      View in: PubMed
    9. Wheeler CM, Hunt WC, Cuzick J, Langsfeld E, Pearse A, Montoya GD, Robertson M, Shearman CA, Castle PE. A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination. Int J Cancer. 2013 Jan 01; 132(1):198-207. PMID: 22532127.
      View in: PubMed
    Langsfeld's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (68) concept(s)
    _
    Co-Authors Expand Description
    See all (3) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)